Cargando…
Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells
Combination therapy as an important treatment option for lung cancer has been attracting attention due to the primary and acquired resistance of chemotherapeutic drugs in the clinical application. In the present study, as a new therapy strategy, concomitant treatment with time-restricted feeding (TR...
Autores principales: | Li, Jianling, Chen, Qianyao, Shi, Dan, Lian, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797463/ https://www.ncbi.nlm.nih.gov/pubmed/36576605 http://dx.doi.org/10.1007/s12032-022-01923-5 |
Ejemplares similares
-
Six-hour time-restricted feeding inhibits lung cancer progression and reshapes circadian metabolism
por: Shi, Dan, et al.
Publicado: (2023) -
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice
por: Fang, Gaofeng, et al.
Publicado: (2023) -
Enhanced Anti‐tumor Effect of Trastuzumab in Combination with Cisplatin
por: Naruse, Ichiro, et al.
Publicado: (2002) -
Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995) -
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)